Associations of Steroid Sex Hormones and Sex Hormone–Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
It remains unclear whether endogenous sex hormones (ESH) are associated with risk of type 2 diabetes (T2D) in women. Data of 3,117 postmenopausal women participants of the Rotterdam Study were analyzed to examine whether ESH and sex hormone–binding globulin (SHBG) were associated with the risk of incident T2D. Additionally, we performed a systematic review and meta-analysis of studies assessing the prospective association of ESH and SHBG with T2D in women. During a median follow-up of 11.1 years, we identified 384 incident cases of T2D in the Rotterdam Study. No association was observed between total testosterone (TT) or bioavailable testosterone (BT) with T2D. SHBG was inversely associated with the risk of T2D, whereas total estradiol (TE) was associated with increased risk of T2D. Similarly, in the meta-analysis of 13 population-based prospective studies involving more than 1,912 incident T2D cases, low levels of SHBG and high levels of TE were associated with increased risk of T2D, whereas no associations were found for other hormones. The association of SHBG with T2D did not change by menopause status, whereas the associations of ESH and T2D were based only in postmenopausal women. SHBG and TE are independent risk factors for the development of T2D in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Nevertheless, FT levels in this study were derived from the ratio of T to SHBG, which is considered a precise proxy for BT (45).”
MethodDing, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176 · cited 1×
“The free androgen index (FAI), calculated as (T/SHBG)*100, is used as a surrogate measure of bioavailable testosterone (BT) (16).”
MethodNESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815
Sex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726 · cited 1×
“SHBG to associate with insulin resistance and T2D, suggesting that altered SHBG physiology may be a primarily defect in the pathogenesis of disease(25-28).”
Backgroundfor the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599 · cited 1×
“Our result for a positive relation between estradiol and T2D are in contrast with the results from previous large randomized control trials of oral estrogen therapy, which showed a lower risk of T2D among postmenopausal women assigned to estrogen treatment(32-34).”
ResultOh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Brand, J. S., van der Tweel, I., Grobbee, D. E., Emmelot-Vonk, M. H., & van der Schouw, Y. T. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq158 · Cited by 334 · cited 1×
“SHBG levels have been associated with metabolic syndrome, glucose, and insulin levels, established risk factors for T2D (7,8,26).”
Background
Research works printed but not linked: 31
- Atsma, 2006, Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis, Menopause, 13, 265, 10.1097/01.gme.0000218683.97338.ea · DOI · Paper page
- Liu, 2001, Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation, Am J Epidemiol, 154, 489, 10.1093/aje/154.6.489 · DOI · Paper page
- Brand, 2013, Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study, Diabetes Care, 36, 1012, 10.2337/dc12-1020 · DOI · Paper page
- Gambineri, 2012, Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study, Diabetes, 61, 2369, 10.2337/db11-1360 · DOI · Paper page
- Kalish, 2003, Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial, J Clin Endocrinol Metab, 88, 1646, 10.1210/jc.2002-021375 · DOI · Paper page
- Brand, 2010, Testosterone, SHBG and cardiovascular health in postmenopausal women, Int J Impot Res, 22, 91, 10.1038/ijir.2009.64 · DOI
- Golden, 2007, Endogenous sex hormones and glucose tolerance status in postmenopausal women, J Clin Endocrinol Metab, 92, 1289, 10.1210/jc.2006-1895 · DOI · Paper page
- Hofman, 2013, The Rotterdam Study: 2014 objectives and design update, Eur J Epidemiol, 28, 889, 10.1007/s10654-013-9866-z · DOI · Paper page
- Leening, 2012, Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study, Eur J Epidemiol, 27, 173, 10.1007/s10654-012-9668-8 · DOI · Paper page
- World Health Organization, 2006, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation, 1
- Rubin, 1987, Multiple imputation for nonresponse in surveys, Invest Radiol
- Rubin, Multiple Imputation for Nonresponse in Surveys, 10.1002/9780470316696 · DOI · Paper page
- Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
- Soriguer, 2012, Testosterone, SHBG and risk of type 2 diabetes in the second evaluation of the Pizarra cohort study, Eur J Invest, 42, 79, 10.1111/j.1365-2362.2011.02559.x · DOI · Paper page
- Boyd-Woschinko, 2007, Androgen excess is associated with insulin resistance and the development of diabetes in African American women, J Cardiometab Syndr, 2, 254, 10.1111/j.1559-4564.2007.06561.x · DOI
- Okubo, 2000, Association of sex hormone-binding globulin and insulin resistance among Japanese-American subjects, Diabetes Res Clin Pract, 47, 71, 10.1016/S0168-8227(99)00106-0 · DOI
- Mather, 2015, Steroid sex hormones, sex hormone-binding globulin, and diabetes incidence in the Diabetes Prevention Program, J Clin Endocrinol Metab, 100, 3778, 10.1210/jc.2015-2328 · DOI · Paper page
- Wang, 2015, Sex hormone-binding globulin associations with circulating lipids and metabolites and the risk for type 2 diabetes: observational and causal effect estimates, Int J Epidemiol, 44, 623, 10.1093/ije/dyv093 · DOI · Paper page
- Zhao, 2005, Study on the (TAAAA)n repeat polymorphism in sex hormone-binding globulin gene and the SHBG serum levels in putative association with the glucose metabolic status of Chinese patients suffering from polycystic ovarian syndrome in Shandong province, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 22, 644
- Rosner, 1999, Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane, J Steroid Biochem Mol Biol, 69, 481, 10.1016/S0960-0760(99)00070-9 · DOI · Paper page
- Catalano, 2005, Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells, Mol Cell Endocrinol, 230, 31, 10.1016/j.mce.2004.11.005 · DOI
- Fortunati, 2010, Sex hormone-binding globulin (SHBG), estradiol and breast cancer, Mol Cell Endocrinol, 316, 86, 10.1016/j.mce.2009.09.012 · DOI
- Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 138, 1, 10.7326/0003-4819-138-1-200301070-00005 · DOI · Paper page
- Bonds, 2006, The effect of conjugated equine oestrogen on diabetes incidence: the Women’s Health Initiative randomised trial, Diabetologia, 49, 459, 10.1007/s00125-005-0096-0 · DOI · Paper page
- Espeland, 1998, Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions, Diabetes Care, 21, 1589, 10.2337/diacare.21.10.1589 · DOI · Paper page
- Zhang, 2002, The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women: the Strong Heart Study, Diabetes Care, 25, 500, 10.2337/diacare.25.3.500 · DOI · Paper page
- Strandberg, 2003, Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women, Am J Cardiol, 92, 212, 10.1016/S0002-9149(03)00542-3 · DOI
- Decensi, 2002, Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women, Circulation, 106, 1224, 10.1161/01.CIR.0000028463.74880.EA · DOI · Paper page
- Lindheim, 1993, A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin, Fertil Steril, 60, 664, 10.1016/S0015-0282(16)56218-9 · DOI · Paper page
- Goodman-Gruen, 2000, Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women, Diabetes Care, 23, 912, 10.2337/diacare.23.7.912 · DOI · Paper page
- Davis, 2012, Understanding weight gain at menopause, Climacteric, 15, 419, 10.3109/13697137.2012.707385 · DOI · Paper page
Cited by
Objectives, design and main findings until 2020 from the Rotterdam Study
Ikram, M. A., Brusselle, G., Ghanbari, M., Goedegebure, A., Ikram, M. K., Kavousi, M., Kieboom, B. C. T., Klaver, C. C. W., de Knegt, R. J., Luik, A. I., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00640-5 · Cited by 452
Self-citationThe Rotterdam Study: 2018 update on objectives, design and main results
Ikram, M. A., Brusselle, G. G. O., Murad, S. D., van Duijn, C. M., Franco, O. H., Goedegebure, A., Klaver, C. C. W., Nijsten, T. E. C., Peeters, R. P., Stricker, B. H., et al. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0321-4 · Cited by 434
Self-citationMauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
Diabetes and cancer: Epidemiological and biological links
Wang, M., Yang, Y., & Liao, Z. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i6.227 · Cited by 158
Marchand, G. B., Carreau, A.-M., Weisnagel, S. J., Bergeron, J., Labrie, F., Lemieux, S., & Tchernof, A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00293.2017 · Cited by 73
O’Reilly, M. W., Glisic, M., Kumarendran, B., Subramanian, A., Manolopoulos, K. N., Tahrani, A. A., Keerthy, D., Muka, T., Toulis, K. A., Hanif, W., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.13862 · Cited by 72
Self-citationDoes the Ketogenic Diet Improve the Quality of Ovarian Function in Obese Women?
Magagnini, M. C., Condorelli, R. A., Cimino, L., Cannarella, R., Aversa, A., Calogero, A. E., & La Vignera, S. (2022) · Nutrients · doi:10.3390/nu14194147 · Cited by 52
Lee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Hedderson, M. M., Capra, A., Lee, C., Habel, L. A., Lee, J., Gold, E. B., Badon, S. E., Mitro, S. D., & El Khoudary, S. R. (2024) · Diabetes Care · doi:10.2337/dc23-1630 · Cited by 17
Raeisi-Dehkordi, H., Amiri, M., Rathmann, W., Zeller, T., Adamski, J., Bano, A., van der Schouw, Y. T., Thorand, B., Muka, T., & Nano, J. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01136-2 · Cited by 11
“…hormones and risk of T2D showed an inverse association of SHBG and risk of T2D in both sexes, although the findings were stron - ger in women than in men [7]; the same inverse association of SHBG with T2D was found in another systematic review and meta-analysis performed exclusively on women [25].”
ResultSelf-citation
Metadata
- Authors
- Muka, T., Nano, J., Jaspers, L., Meun, C., Bramer, W. M., Hofman, A., Dehghan, A., Kavousi, M., Laven, J. S. E., & Franco, O. H.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-10-10
- Volume
- 66
- Issue
- 3
- Pages
- 577-586
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2531432849
- Cited by
- 140
- References
- 16
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Metagenics Inc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.